Matthew Shun-Shin Profile
Matthew Shun-Shin

@mshunshin

Followers
886
Following
858
Statuses
661

I've moved to Bluesky: https://t.co/PqV0EohgZJ Clinical Senior Lecturer and Consultant Cardiologist

London, England
Joined August 2011
Don't wanna be here? Send us removal request.
@mshunshin
Matthew Shun-Shin
3 months
Moved to Bluesky Follow me at:
0
0
0
@mshunshin
Matthew Shun-Shin
6 months
@hmkyale @NEJM I am however enjoying the rest of their FAQ. "My computer is broken. Can I send my manuscript the old-fashioned way?"... "No."
0
0
2
@mshunshin
Matthew Shun-Shin
8 months
RT @JACCJournals: 📢 Calling all researchers! Submit to #JACC for: ✅ Easy submissions ⏩ Rapid reviews 💡 Constructive feedback 📊 High-qualit…
0
15
0
@mshunshin
Matthew Shun-Shin
8 months
RT @rallamee: Just in case you thought the ORBITA team had gone on summer vacation… The first ORBITA-MOON case was completed yesterday. Ano…
0
12
0
@mshunshin
Matthew Shun-Shin
8 months
What a great first edition of @JACCJournals under @hmkyale. Amazing pieces by Milton Packer and @DrCaliff_FDA; with original research by @dr_m_fontana and @rallamee (ORBITA-STAR and ORBITA-Symptoms).
0
3
24
@mshunshin
Matthew Shun-Shin
9 months
@f2harrell @VickersBiostats @rajkumar_chris @rallamee @MikeFoley89 @FloSimader @fiyyazAJ @DrKeeble @DrPeterOKane @JACCJournals @PCRonline @SukhNijjer @ProfDFrancis Thanks for the thoughts - with the flexibility of the approach and tools available in "rmsb" we have a lot of options for producing clinical useful estimands. We are finding our way in which ones resonate with clinicians and how to effectively present them.
0
0
2
@mshunshin
Matthew Shun-Shin
9 months
As ever, with the statistical methods developed by @f2harrell, the 22,823 patient-days of symptoms data are utilised, based on work detailed here: Perhaps one day Bayesian ordinal longitudinal models will be used by all trials...
1
2
10
@mshunshin
Matthew Shun-Shin
9 months
RT @JACCJournals: ICYMI: Watch Drs. @rallamee and @FloSimader shed light on their #JACC paper discussing symptoms as a predictor of the pla…
0
2
0
@mshunshin
Matthew Shun-Shin
9 months
RT @JACCJournals: .@FloSimader on #ORBITA-2 at #EuroPCR: 📌Poor correlation between symptoms & disease severity 📌Symptom nature is a powerfu…
0
8
0
@mshunshin
Matthew Shun-Shin
9 months
RT @MikeFoley89: The symptom stratified analysis of ORBITA2 and the ORBITA-STAR trial both presented at #EuroPCR2024 and simultaneously pub…
0
19
0
@mshunshin
Matthew Shun-Shin
9 months
RT @AnilMakam: In contention for BEST study of the year thus far N of 1 trial of patient-blinded occlusion of target vessel The more ang…
0
4
0
@mshunshin
Matthew Shun-Shin
9 months
RT @JACCJournals: #EuroPCR #JACC LBCT SimPub: #ORBITA-2 symptom-stratified analysis - Although symptom severity & nature were poorly associ…
0
11
0